Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Kidney International Reports Year : 2018

Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy

Abstract

no abstract
Fichier principal
Vignette du fichier
KidneyIR2018.pdf (910.2 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-02193809 , version 1 (24-07-2019)

Identifiers

Cite

Lena Berchtold, Gilbert Zanetta, Karine Dahan, Fabrice Mihout, Julie Peltier, et al.. Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy. Kidney International Reports, 2018, 3 (2), pp.486-491. ⟨10.1016/j.ekir.2017.09.009⟩. ⟨inserm-02193809⟩
55 View
66 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More